Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Fulcrum Therapeutics Inc

FULC
Current price
3.29 USD +0.24 USD (+7.87%)
Last closed 2.72 USD
ISIN US3596161097
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 177 591 888 USD
Yield for 12 month -54.62 %
1Y
3Y
5Y
10Y
15Y
FULC
21.11.2021 - 28.11.2021

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers drug targets for potential treatment inherited aplastic anemias, such as of diamond-blackfan anemia, shwachman-diamond syndrome, and fanconi anemia, as well as novel fetal hemoglobin inducers, fibrotic disorders, and cardiomyopathies which is in preclinical trial. It has collaboration and license agreement with MyoKardia, Inc. to identify biological targets that are capable of modulating genes of interest with relevance to cardiomyopathies; and licensce agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize; and Sanofi for the development and commercialization of losmapimod, an oral small molecule being investigated for the treatment of facioscapulohumeral muscular dystrophy. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: 26 Landsdowne Street, Cambridge, MA, United States, 02139

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.67 USD

P/E ratio

Dividend Yield

Current Year

+80 000 000 USD

Last Year

+2 805 000 USD

Current Quarter

Last Quarter

Current Year

+80 000 000 USD

Last Year

+2 805 000 USD

Current Quarter

Last Quarter

Key Figures FULC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -18 241 000 USD
Operating Margin TTM -24.79 %
Price to Earnings
Return On Assets TTM -4.78 %
PEG Ratio
Return On Equity TTM -4.07 %
Wall Street Target Price 5.67 USD
Revenue TTM 80 000 000 USD
Book Value 4.50 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100.00 %
Dividend Yield
Gross Profit TTM 16 614 000 USD
Earnings per share -0.16 USD
Diluted Eps TTM -0.16 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin -12.16 %

Dividend Analytics FULC

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History FULC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation FULC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 117.40
Price Sales TTM 2.22
Enterprise Value EBITDA -3.09
Price Book MRQ 0.73

Financials FULC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators FULC

For 52 weeks

2.32 USD 10.13 USD
50 Day MA 3.20 USD
Shares Short Prior Month 5 219 364
200 Day MA 4.81 USD
Short Ratio 8.45
Shares Short 3 733 393
Short Percent 8.96 %